Before jumping directly into momentum stocks worth buying now, it’s important to understand what momentum trading is. As the name implies, momentum trading relies on reacting to the current movement of a stock or sector. A good screener from which to identify current momentum stocks can be found here . The theory then goes that momentum investors sell shares that are trending down and buy those that are trending up. While the strategy flies in the face of the age-old adage to ‘buy low, sell high’, some research suggests it has merit. AQR Capital Management is one of the more prominent proponents of the strategy. Ronen Israel, a principal at the firm, has defended the strategy at multiple high-level conferences providing evidence that the strategy has produced strong returns and tax efficiency similar to value investing. CLMT Calumet Specialty Partners $14.44 KRTX Karuna Therapeutics $226.12 LQDA Liquidia $5.28 HDSN Hudson Technologies $6.90 LNTH Lantheus Holdings $68.36 IRTC iRhythm Technologies $18.00 VERU Veru $10.22 Calumet Specialty Partners (CLMT) Source: Oil and Gas Photographer / Shutterstock Calumet Specialty Partners (NASDAQ: CLMT ) stock represents a specialty hydrocarbon products company that has maintained positive momentum since early July.
The following slide deck was published by Calumet Specialty Products Partners, L.P.
Louis Todd Borgmann , Chief Executive Officer at Calumet Specialty (NASDAQ: CLMT ), reported a large insider buy on August 30, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Borgmann purchased 7,093 shares of Calumet Specialty. The total transaction amounted to $125,000. Calumet Specialty shares are trading down 0.53% at $16.81 at the time of this writing on Wednesday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily … Full story available on Benzinga.com
According to Benzinga Pro data, during Q2, Calumet Specialty (NASDAQ: CLMT ) posted sales of $1.42 billion. Earnings were up 83.98%, but Calumet Specialty still reported an overall loss of $15.30 million. Calumet Specialty collected $1.10 billion in revenue during Q1, but reported earnings showed a $95.50 million loss. What Is Return On Capital Employed? Return on Capital Employed is a measure of yearly pre-tax profit relative to capital employed by a business. Changes in earnings and sales indicate shifts in a company''s ROCE. A higher ROCE is generally representative of successful growth … Full story available on Benzinga.com
Calumet reported a through-the-roof record of $175 million in EBITDA far above the most bullish estimates. Significantly higher cash flow will continue. Read more.
https://www.investing.com/news/pro/goldman-sachs-upgrades-calumet-specialty-products-partners-to-buy-432SI-2875302
U.S. stocks closed mixed on Friday following the release of jobs data for July. Here is the list of some big stocks moving higher in the previous session. Carvana Co. (NYSE: CVNA ) jumped 40.1% to close at $46.98 after the company reported Q2 earnings results. Progyny, Inc. (NASDAQ: PGNY ) jumped 38.2% to close at $41.15 after the company reported better-than-expected Q2 results. Global Blood Therapeutics, Inc. (NASDAQ: GBT ) rose 33% to settle at $63.84 following reports suggesting Pfizer is in talks to acquire the company. Sensus Healthcare, Inc. (NASDAQ: SRTS ) surged 30.7% to close at $14.55 following strong quarterly results. Pagaya Technologies Ltd. (NASDAQ: PGY ) climbed 28.7% to close at $22.76 after dipping 34% on Thursday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022. Cloudflare, Inc. (NYSE: NET ) shares gained 27.1% to close at $74.24 after the company reported better-than-expected Q2 sales and raised FY22 sales guidance. Atlas Corp. (NYSE: ATCO ) gained 22.9% to close at $14.22 after the company said it received a non-binding proposal from Poseidon Acquisition Corp. to acquire all outstanding common shares of Atlas for $14.45 per share.
U.S. stocks traded mostly lower toward the end of trading, following the release of jobs data The Dow traded down 0.01% to 32,724.99 while the NASDAQ fell 0.92% to 12,604.01. The S&P also fell, dropping, 0.49% to 4,131.45. Also check this: Lyft, DoorDash, Expedia And Some Other Big Stocks Moving Higher In Today''s Pre-Market Session Leading and Lagging Sectors Energy shares climbed 2.3% on Friday. Meanwhile, top gainers in the sector included Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT ), up 19% and (NASDAQ: AMTX ) up 23%. In trading on Friday, consumer discretionary shares fell 2.2%. Top Headline The U.S. added 528,000 jobs in July, beating consensus economist estimates of 258,000 jobs. The unemployment rate dropped from 3.6% to 3.5%, returning to its pre-COVID pandemic level. Wages were up 5.2% from a year ago and by 0.5% from June. Equities Trading UP Athenex Inc (NASDAQ: ATNX ) shares shot up 48% to $0.93 as India''s Intas Pharmaceuticals and Dr Reddy''s Laboratories Ltd are reportedly in talks to acquire Athenex.
Start Time: 09:00 End Time: 09:48 Calumet Specialty Products Partners, L.P.
Gainers: Aemetis (AMTX) +28%. Clean Energy Fuels (CLNE) +21%. Calumet Specialty Products Partners (CLMT) +18%. Losers: IAMGOLD (IAG) -10%
Calumet Specialty (CLMT) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open.The consensus EPS Estimate is $0.17 (+117.5% Y/Y) and the consensus…
Calumet Specialty (NASDAQ: CLMT ) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here''s what investors need to know before the announcement. Analysts estimate that Calumet Specialty will report an earnings per share (EPS) of $0.27. Calumet Specialty bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com
Calumet is set to report more than stellar earnings with cash flow from operations above $100 million. See why CLMT’s $9 share price is a buying opportunity gift.
Europe, Univar B.V., a subsidiary of Univar Solutions (UNVR) said Tuesday that it has expanded its distribution pact with Calumet Specialty Products (CLMT) for their range of naphthenic…
The expansion aims to build on the companies'' existing partnership across Europe and North America and solidifies Univar Solutions'' lubricants and metalworking fluids portfolio. ROTTERDAM, Netherlands, July 12, 2022 /PRNewswire/ -- Europe, Univar B.V., a subsidiary of Univar Solutions Inc….
U.S. stocks traded higher midway through trading, with the Dow Jones jumping more than 200 points following the release of data on initial jobless claims. The Dow traded up 0.77% to 31,275.90 while the NASDAQ rose 1.71% to 11,556.29. The S&P also rose, gaining, 1.13% to 3,888.56. Also check this: U.S. Trade Deficit Might Shrink This Much In May, Here''s The Major Macro Issues For Thursday Leading and Lagging Sectors Energy shares rose by 3.7% on Thursday. Meanwhile, top gainers in the sector included Consumer Staples (NYSE: CPG ), up 14% and Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT ) up 13%. In trading on Thursday, consumer staples shares dipped by 0.3%. Top Headline Samsung Electronics Co, Ltd (OTC: SSNLF ) announced its earnings guidance for the second quarter of 2022. Samsung expects consolidated sales of 77 trillion Korean won, up 20.9% year on year (versus actual sales of 63.67 trillion Korean won in Q2 2021). It expects a consolidated operating profit of 14 trillion Korean won, up 11.4% Y/Y (versus an actual operating profit of 12.57 trillion Korean won in Q2 2021).
Analysts expect Calumet Specialty Products Partners, L.P. to report earnings per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have…
Calumet reported soft, but expected, numbers at its last conference call at $35 million cash. Read more about CLMT stock here.
The following slide deck was published by Calumet Specialty Products Partners, L.P.
Announcement of Periodic Review: Moody''s announces completion of a periodic review of ratings of Calumet Specialty Products Partners, L.P. Read the full article at Moody''s
INDIANAPOLIS, June 9, 2021 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT), today announced that senior management will participate in the Bank of America Merrill Lynch…
Related Stocks: CLMT ,
Calumet Specialty Products Partners L.P. shares closed 2.4% higher than its previous 52 week high, giving the company a market cap of $423M. The stock is currently up 72.2% year-to-date, up 188.2% over the past 12 months, and down 53.4% over the past five years. This week, the Dow Jones Industrial Average rose 3.7%, and the S&P 500 rose 3.8%. Trading Activity Trading volume this week was 54.0% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 68.8% The company's stock price performance over the past 12 months beats the peer average by 79.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Calumet Specialty Products Partners (CLMT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Recipient of Largest Reported PPP Loan, Calumet Specialty, Bragged About Strong Financials Days After Accepting Aid Watchdog Calls on Company to Return $31.4M in Aid… The post Calumet Specialty brags about strong financials days after accepting aid appeared first on .
Investors need to pay close attention to Calumet Specialty Products (CLMT) stock based on the movements in the options market lately.
Is (CLMT) Outperforming Other Oils-Energy Stocks This Year?
Calumet Specialty Products Partners, L.P. (CLMT) closed the most recent trading day at $4.17, moving +1.21% from the previous trading session.
Is (CLMT) Outperforming Other Oils-Energy Stocks This Year?
As of late, it has definitely been a great time to be an investor in Calumet Specialty Products Partners, L.P. (CLMT).
CLMT earnings call for the period ending March 31, 2019.